ArticleThe plant pathology journal2013
Taxonomic Re-evaluation of Colletotrichum gloeosporioides Isolated from Strawberry in Korea.
Article in The plant pathology journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Diversity and Host Associations of the Genus Colletotrichum in Korea.The plant pathology journal · 2026Review
- Re-identification of Colletotrichum gloeosporioides Species Complex Isolates in Korea and Their Host Plants.The plant pathology journal · 2024Article
- Genome-wide association study of resistance to anthracnose in pepper (Capsicum chinense) germplasm.BMC plant biology · 2023Article
- Article
- Co-treatment with Origanum Oil and Thyme Oil Vapours Synergistically Limits the Growth of Soil-borne Pathogens Causing Strawberry Diseases.The plant pathology journal · 2022Article
- Pest categorisation ofEFSA journal. European Food Safety Authority · 2021Article
- Chemical Fungicides andThe plant pathology journal · 2021Article
- Phospholipid signaling pathway in Capsicum chinense suspension cells as a key response to consortium infection.BMC plant biology · 2021Article
- Draft Genome Sequence of the Strawberry Anthracnose PathogenMicrobiology resource announcements · 2020Article
- Identification and Characterization ofThe plant pathology journal · 2018Article
- Article
- Novel Fungal Pathogenicity and Leaf Defense Strategies Are Revealed by Simultaneous Transcriptome Analysis ofFrontiers in plant science · 2018Article
- Identification and Characterization of New Record of Grape Ripe Rot Disease Caused byMycobiology · 2017Article
- Characterization and Pathogenicity of New Record of Anthracnose on Various Chili Varieties Caused byMycobiology · 2017Article
- First Report of Anthracnose Caused byMycobiology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the past two decades, the causal agent of anthracnose occurring on strawberry in Korea was considered Colletotrichum gloeosporioides. However, the recent molecular analysis has shown that the genus Colletotrichum has undergone many taxonomic changes with introduction of several new species. As a result, it revealed that C. gloeosporioides indeed consisted of more than 20 distinct species. Therefore, the Korean pathogen isolated from strawberry should be reclassified. The shape and size of the conidia of the pathogen were not distinctly different from those of C. gloeosporioides and C. fructicola, but it differed in shape of the appressoria. A combined sequence analysis of partial actin, glycer-aldehydes-3-phosphate dehydrogenase genes, and the internal transcribed spacer regions showed that the strawberry isolates formed a monophyletic group with authentic strains of C. fructicola. On the basis of these results, the anthracnose fungi of the domestic strawberry in Korea were identified as C. fructicola and distinguished from C. gloeosporioides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.